Anavex Life Sciences Corp (AVXL)

[nidan7500]

Excellent-rational post tradeherpete...thx

For efficacy, see the first P2a, 32 person Australian trial. They had unexpected efficacy shown in several participants but it didn’t have a placebo arm and wasn’t a large enough, properly powered P3 trial. Prof. Macfarlane pointed this out in a video interview, discussing the results.

In the next five weeks there will be Press Release by Anavex letting us know if the primary and secondary endpoints were met. If they were, then we are golden, if they weren’t, then we have to hear the details to see what they found. They should have told us if they weren’t met by now so the assumption is, they were.

The trial is properly powered, as Prof. Macfarlane stipulated in his video interview, otherwise I doubt he would travel a long way to tell us it wasn’t. Anavex has scheduled a late breaking entry at Ctad, there are also first hand anecdotal reports of many participants appearing much happier, outgoing and resuming life activities.

Therefor, I assume we are in for a positive readout in November or Dec 1, at the latest.